Mechanisms of type-I- and type-II-interferon-mediated signalling

Leonidas C. Platanias

DOI: https://doi.org/10.1038/nri1604

IF: 108.555

2005-05-01

Nature Reviews Immunology

Abstract:Key PointsThere are two main classes of interferon (IFN): type I IFNs and type II IFN. There are many type I IFNs, including IFN-α, IFN-β and IFN-ω, and all of these bind a common cell-surface receptor. IFN-γ, the only type II IFN, initiates signalling by binding a distinct receptor at the cell surface.Type I and type II IFNs activate both common and distinct STAT (signal transducer and activator of transcription) complexes, which regulate the transcription of target genes.In addition to the classical Janus activated kinase (JAK)–STAT-signalling pathways, both type I and type II IFNs activate several other signalling cascades.CRKL, a member of the CRK family of proteins, is activated by both type I and type II IFNs, and it functions as a nuclear adaptor for STAT5 and/or as an upstream regulator of a signalling pathway that involves the guanine-nucleotide-exchange factor C3G and RAP1.The mitogen-activated protein kinase p38 is activated by type I IFNs and has a crucial role in the type-I-IFN-dependent transcription of genes and in the generation of the antiproliferative and antiviral effects of type I IFNs.Both type I and type II IFNs regulate activation of the phosphatidylinositol 3-kinase (PI3K)-signalling pathway. One of the downstream effectors of PI3K is protein kinase C-δ, which functions as a serine kinase for STAT1.At least two distinct pathways for the regulation of mRNA translation are activated downstream of IFN-activated PI3K and mammalian target of rapamycin (MTOR). One involves activation of p70 S6 kinase and phosphorylation of ribosomal protein S6, and the other involves phosphorylation and deactivation of the translational repressor 4EBP1 (eukaryotic translation-initiation factor 4E (EIF4E)-binding protein 1).

immunology